496 related articles for article (PubMed ID: 19415007)
1. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
Brown K; Subramony C; May W; Megason G; Liu H; Bishop P; Walker T; Nowicki MJ
J Pediatr Hematol Oncol; 2009 May; 31(5):309-12. PubMed ID: 19415007
[TBL] [Abstract][Full Text] [Related]
2. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
[TBL] [Abstract][Full Text] [Related]
3. [Iron overload in sickle cell anemia : a study of 94 patients].
Hafsia R; Belakhal F; Ben Salah N; Gouider E; Elborgi W
Tunis Med; 2011 Jun; 89(6):548-52. PubMed ID: 21681718
[TBL] [Abstract][Full Text] [Related]
4. Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study.
Silva IS; Perez RM; Oliveira PV; Cantagalo MI; Dantas E; Sisti C; Figueiredo-Mendes C; Lanzoni VP; Silva A; Ferraz ML
J Gastroenterol Hepatol; 2005 Feb; 20(2):243-8. PubMed ID: 15683427
[TBL] [Abstract][Full Text] [Related]
5. Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention.
Kwiatkowski JL; Cohen AR; Garro J; Alvarez O; Nagasubramanian R; Sarnaik S; Thompson A; Woods GM; Schultz W; Mortier N; Lane P; Mueller B; Yovetich N; Ware RE;
Am J Hematol; 2012 Feb; 87(2):221-3. PubMed ID: 22120913
[TBL] [Abstract][Full Text] [Related]
6. Ferritin and LIC: predicting liver injury in children with sickle cell.
Smith E; Lebensburger J; Hilliard L; Kelly D; Fineberg N; Bai S; Howard T
J Pediatr Gastroenterol Nutr; 2014 Mar; 58(3):387-90. PubMed ID: 24553473
[TBL] [Abstract][Full Text] [Related]
7. Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia major.
Sievert W; Pianko S; Warner S; Bowden S; Simpson I; Bowden D; Locarnini S
Am J Gastroenterol; 2002 Apr; 97(4):982-7. PubMed ID: 12003436
[TBL] [Abstract][Full Text] [Related]
8. Liver biopsy results in patients with sickle cell disease on chronic transfusions: poor correlation with ferritin levels.
Karam LB; Disco D; Jackson SM; Lewin D; McKie V; Baker RD; Baker SS; Laver JH; Nietert PJ; Abboud MR
Pediatr Blood Cancer; 2008 Jan; 50(1):62-5. PubMed ID: 17457853
[TBL] [Abstract][Full Text] [Related]
9. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy.
Harmatz P; Butensky E; Quirolo K; Williams R; Ferrell L; Moyer T; Golden D; Neumayr L; Vichinsky E
Blood; 2000 Jul; 96(1):76-9. PubMed ID: 10891433
[TBL] [Abstract][Full Text] [Related]
10. Microarray analysis of liver gene expression in iron overloaded patients with sickle cell anemia and beta-thalassemia.
Flanagan JM; Steward S; Hankins JS; Howard TM; Neale G; Ware RE
Am J Hematol; 2009 Jun; 84(6):328-34. PubMed ID: 19384939
[TBL] [Abstract][Full Text] [Related]
11. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.
Fung EB; Harmatz P; Milet M; Ballas SK; De Castro L; Hagar W; Owen W; Olivieri N; Smith-Whitley K; Darbari D; Wang W; Vichinsky E;
Am J Hematol; 2007 Apr; 82(4):255-65. PubMed ID: 17094096
[TBL] [Abstract][Full Text] [Related]
12. Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.
Badawy SM; Liem RI; Rigsby CK; Labotka RJ; DeFreitas RA; Thompson AA
Br J Haematol; 2016 Nov; 175(4):705-713. PubMed ID: 27507431
[TBL] [Abstract][Full Text] [Related]
13. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.
Mazza P; Giua R; De Marco S; Bonetti MG; Amurri B; Masi C; Lazzari G; Rizzo C; Cervellera M; Peluso A
Haematologica; 1995; 80(5):398-404. PubMed ID: 8566878
[TBL] [Abstract][Full Text] [Related]
14. Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia.
Vichinsky E; Butensky E; Fung E; Hudes M; Theil E; Ferrell L; Williams R; Louie L; Lee PD; Harmatz P
Am J Hematol; 2005 Sep; 80(1):70-4. PubMed ID: 16138345
[TBL] [Abstract][Full Text] [Related]
15. Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies.
Jastaniah W; Harmatz P; Pakbaz Z; Fischer R; Vichinsky E; Walters MC
Pediatr Blood Cancer; 2008 Feb; 50(2):319-24. PubMed ID: 17557314
[TBL] [Abstract][Full Text] [Related]
16. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
[TBL] [Abstract][Full Text] [Related]
17. Nontransferrin-bound iron in transfused patients with sickle cell disease.
Inati A; Musallam KM; Cappellini MD; Duca L; Taher AT
Int J Lab Hematol; 2011 Apr; 33(2):133-7. PubMed ID: 21382180
[TBL] [Abstract][Full Text] [Related]
18. Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C.
Di Marco V; Capra M; Gagliardotto F; Borsellino Z; Cabibi D; Barbaria F; Ferraro D; Cuccia L; Ruffo GB; Bronte F; Di Stefano R; Almasio PL; Craxì A
Haematologica; 2008 Aug; 93(8):1243-6. PubMed ID: 18556410
[TBL] [Abstract][Full Text] [Related]
19. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
[TBL] [Abstract][Full Text] [Related]
20. Patterns of liver iron accumulation in patients with sickle cell disease and thalassemia with iron overload.
Hankins JS; Smeltzer MP; McCarville MB; Aygun B; Hillenbrand CM; Ware RE; Onciu M
Eur J Haematol; 2010 Jul; 85(1):51-7. PubMed ID: 20374273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
